The Asd+-DadB+ dual-plasmid system offers a novel means to deliver multiple protective antigens by a recombinant attenuated Salmonella vaccine

Infection and Immunity

Volumn 80, Issue 10, 2012, Pages 3621-3633

  Xin, Wei ^a   Wanda, Soo Young ^a   Zhang, Xiangmin ^a   Santander, Javier ^a   Scarpellini, Giorgio ^a   Ellis, Karen ^a   Alamuri, Praveen ^a   Curtiss III, Roy ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DEXTRO ALANINE; DIAMINOPIMELIC ACID; RECOMBINANT ATTENUATED SALMONELLA VACCINE; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CONTROLLED STUDY; FEMALE; GENE MUTATION; IMMUNIZATION; MOUSE; NONHUMAN; PLASMID; PNEUMONIA; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PLASMIDS; PNEUMONIA, PNEUMOCOCCAL; RECOMBINANT PROTEINS; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SALMONELLA VACCINES; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 84867610365     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00620-12     Document Type: Article

References (44)

1. Arulanandam BP, Lynch JM, Briles DE, Hollingshead S, Metzger DW. 2001. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. Infect. Immun. 69: 6718-6724.
2. Badet B, Roise D, Walsh CT. 1984. Inactivation of the dadB Salmonella typhimurium alanine racemase by D and L isomers of beta-substituted alanines: kinetics, stoichiometry, active site peptide sequencing, and reaction mechanism. Biochemistry 23: 5188-5194.
3. Briles DE, et al. 1996. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine 14: 858-867.
4. Curtiss R, III, Goldschmidt RM, Fletchall NB, Kelly SM. 1988. Avirulent Salmonella typhimurium delta cya delta crp oral vaccine strains expressing a streptococcal colonization and virulence antigen. Vaccine 6: 155-160.
5. Curtiss R, III, Kelly SM, Gulig PA, Nakayama K. 1989. Stable recombinant avirulent Salmonella vaccine strains. Adv. Exp. Med. Biol. 251: 33-47.
6. Curtiss R, III, et al. 1994. Recombinant Salmonella vectors in vaccine development. Dev. Biol. Stand. 82: 23-33.
7. Curtiss R, III, Nakayama K, Kelly SM. 1989. Recombinant avirulent Salmonella vaccine strains with stable maintenance and high level expression of cloned genes in vivo. Immunol. Invest. 18: 583-596.
8. Curtiss R, III, et al. 2010. New technologies in using recombinant attenuated Salmonella vaccine vectors. Crit. Rev. Immunol. 30: 255-270.
9. Curtiss R, et al. 1991. Nonrecombinant and recombinant avirulent Salmonella live vaccines for poultry, p 169-198. In Colonization control of human bacterial enteropathogens in poultry. Academic Press, Inc., New York, NY.
10. Fauconnier A, Van Elsen A, Bollen A. 1998. Construction and sequencing of new derivatives of the pIN-III-ompA secretion vector. Genet. Anal. 14: 129-131.
11. Galakatos NG, Daub E, Botstein D, Walsh CT. 1986. Biosynthetic alr alanine racemase from Salmonella typhimurium: DNA and protein sequence determination. Biochemistry 25: 3255-3260.
12. Galakatos NG, Walsh CT. 1989. Mutations at the interdomain hinge region of the DadB alanine racemase: effects of length and conformational constraint of the linker sequence on catalytic efficiency. Biochemistry 28: 8167-8174.
13. Galán JE, Nakayama K, Curtiss R III. 1990. Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 94: 29-35.
14. Galen JE, et al. 2009. Salmonella enterica serovar Typhi live vector vaccines finally come of age. Immunol. Cell Biol. 87: 400-412.
15. Galen JE, et al. 2010. A new generation of stable, nonantibiotic, low-copynumber plasmids improves immune responses to foreign antigens in Salmonella enterica serovar Typhi live vectors. Infect. Immun. 78: 337-347.
16. Gunn BM, Wanda SY, Burshell D, Wang C, Curtiss R III. 2010. Construction of recombinant attenuated Salmonella enterica serovar typhimurium vaccine vector strains for safety in newborn and infant mice. Clin. Vaccine Immunol. 17: 354-362.
17. Hitchcock PJ, Brown TM. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154: 269-277.
18. Hopkins S, et al. 1995. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect. Immun. 63: 3279-3286.
19. Kang HY, Dozois CM, Tinge SA, Lee TH, Curtiss R III. 2002. Transduction-mediated transfer of unmarked deletion and point mutations through use of counterselectable suicide vectors. J. Bacteriol. 184: 307-312.
20. Kang HY, Srinivasan J, Curtiss R III. 2002. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect. Immun. 70: 1739-1749.
21. Li Y, et al. 2009. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc. Natl. Acad. Sci. U.S.A. 106: 593-598.
22. Li Y, et al. 2008. A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines. Infect. Immun. 76: 5238-5246.
23. Mahan MJ, Slauch JM, Mekalanos JJ. 1993. Selection of bacterial virulence genes that are specifically induced in host tissues. Science 259: 686-688.
24. Meli R, et al. 2003. Th1-Th2 response in hyperprolactinemic mice infected with Salmonella enterica serovar Typhimurium. Eur. Cytokine Netw. 14: 186-191.
25. Moffitt KL, et al. 2011. T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Cell Host Microbe 9: 158-165.
26. Moffitt KL, Yadav P, Weinberger DM, Anderson PW, Malley R. 2012. Broad antibody and T cell reactivity induced by a pneumococcal wholecell vaccine. Vaccine 30: 4316-4322.
27. + expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio/Technology 6: 693-697.
28. Niemann GS, et al. 2011. Discovery of novel secreted virulence factors from Salmonella enterica serovar Typhimurium by proteomic analysis of culture supernatants. Infect. Immun. 79: 33-43.
29. O'Garra A, Arai N. 2000. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 10: 542-550.
30. Roche H, Ren B, McDaniel LS, Hakansson A, Briles DE. 2003. Relative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniae. Infect. Immun. 71: 4498-4505.
31. Ross P, O'Gara F, Condon S. 1990. Thymidylate synthase gene from Lactococcus lactis as a genetic marker: an alternative to antibiotic resistance genes. Appl. Environ. Microbiol. 56: 2164-2169.
32. Santander J, Xin W, Yang Z, Curtiss R. 2010. The aspartate-semialdehyde dehydrogenase of Edwardsiella ictaluri and its use as balanced-lethal system in fish vaccinology. PLoS One. doi: 10.1371/journal.pone.0015944 5: e15944
33. Sørensen KI, Larsen R, Kibenich A, Junge MP, Johansen E. 2000. A food-grade cloning system for industrial strains of Lactococcus lactis. Appl. Environ. Microbiol. 66: 1253-1258.
34. Spellberg B, Edwards JE, Jr. 2001. Type 1/type 2 immunity in infectious diseases. Clin. Infect. Dis. 32: 76-102.
35. Srinivasan J, Nayak A, Curtiss R III, Rubino S. 1995. Effect of the route of immunization using recombinant Salmonella on mucosal and humoral immune responses, p 273-280. In Brown F, Chanock R, Ginsberg H, Norrby E (ed), Vaccines. Cold Spring Harbor Laboratory Press, Plainview, NY.
36. Tauch A, Gotker S, Puhler A, Kalinowski J, Thierbach G. 2002. The alanine racemase gene alr is an alternative to antibiotic resistance genes in cloning systems for industrial Corynebacterium glutamicum strains. J. Biotechnol. 99: 79-91.
37. Wang S, et al. 2010. Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity. Infect. Immun. 78: 3969-3980.
38. Wang S, et al. 2010. Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine. Infect. Immun. 78: 3258-3271.
39. Wasserman SA, Walsh CT, Botstein D. 1983. Two alanine racemase genes in Salmonella typhimurium that differ in structure and function. J. Bacteriol. 153: 1439-1450.
40. Wu HY, Nahm MH, Guo Y, Russell MW, Briles DE. 1997. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J. Infect. Dis. 175: 839-846.
41. Xin W, Li Y, Mo H, Roland KL, Curtiss R III. 2009. PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae. Infect. Immun. 77: 4518-4528.
42. Xin W, et al. 2008. Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis. Infect. Immun. 76: 3241-3254.
43. Yang X, et al. 2007. Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J. Immunol. 178: 1059-1067.
44. Zhang X, Wanda SY, Brenneman K, Kong W, Roland K, Curtiss R III. 2011. Improving Salmonella vector with rec mutation to stabilize theDNA cargoes. BMC Microbiol. doi: 10.1186/1471-2180-11-31 11: 31